M, W., JP, P., M, M., F, L., S, C., R, L., . . . C, V. (2026). Pyrogenicity of phage active pharmaceutical ingredients used for personalized therapy in Belgium. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 223, 115068. https://doi.org/10.1016/j.ejpb.2026.115068
Chicago Style (17th ed.) CitationM, Willocx, Pirnay JP, Merabishvili M, Laurent F, Clouet S, Lavigne R, Ceyssens PJ, and Vanhee C. "Pyrogenicity of Phage Active Pharmaceutical Ingredients Used for Personalized Therapy in Belgium." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V 223 (2026): 115068. https://doi.org/10.1016/j.ejpb.2026.115068.
MLA (9th ed.) CitationM, Willocx, et al. "Pyrogenicity of Phage Active Pharmaceutical Ingredients Used for Personalized Therapy in Belgium." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V, vol. 223, 2026, p. 115068, https://doi.org/10.1016/j.ejpb.2026.115068.